Notícias Amylin Pharmaceuticals, Inc. (MM) - AMLN | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Amylin Pharmaceuticals, Inc. (MM) (AMLN)
Amylin Pharmaceuticals, Inc. (MM) (AMLN) Notícias

Amylin Pharmaceuticals, Inc. (MM) (AMLN)

30,98

0,00

(0,00%)

Fechado 04 Dezembro 6:00PM

Atrasado por 15 minutos

0,00

0,00

(0,00%)

Após o horário de negociação: -

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Amended Statement of Ownership: Solicitation (SC 14D9/A)

- Amended tender offer statement by Third Party (SC TO-T/A)

- Amended tender offer statement by Third Party (SC TO-T/A)

- Amended Statement of Ownership: Solicitation (SC 14D9/A)

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...

Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It...

- Tender offer statement by Third Party (SC TO-T)

Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.

Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.

- Written communication by the subject company relating to a third party tender offer (SC14D9C)

- Statement of Changes in Beneficial Ownership (4)

1
2
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições